{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:25:03Z","timestamp":1793395503211,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["R.G.P. 1\/430\/44"],"award-info":[{"award-number":["R.G.P. 1\/430\/44"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["R.G.P. 2\/183\/44"],"award-info":[{"award-number":["R.G.P. 2\/183\/44"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bioorg.2024.107228","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T11:54:17Z","timestamp":1708516457000},"page":"107228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["N- and s-substituted Pyrazolopyrimidines: A promising new class of potent c-Src kinase inhibitors with prominent antitumor activity"],"prefix":"10.1016","volume":"145","author":[{"given":"Aeshah A.","family":"Awaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waheed Ali Zaki El","family":"Zaloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Seleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Alswah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Elsebaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf H.","family":"Bayoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"El-Morsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Y.","family":"Alfaifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"Shati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serag Eldin I.","family":"Elbehairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Almaghrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed K.B.","family":"Aljohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany E.A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107228_b0005","doi-asserted-by":"crossref","unstructured":"S.B. G.W. Prager, B. Bystricky, C. Qvortrup, C. Criscitiello, E. Esin, G.S. Sonke, G. Mart\u00ednez, J.-S. Frenel, M. Karamouzis, Global cancer control: responding to the growing burden, rising costs and inequalities in access, ESMO open, 3 (2018) e000285., 92(1) 1-3.","DOI":"10.1136\/esmoopen-2017-000285"},{"key":"10.1016\/j.bioorg.2024.107228_b0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pbiomolbio.2022.09.009","article-title":"Cancer \u2013 A devastating disease, but also an eye-opener and window into the deep mysteries of life and its origins","volume":"175","author":"Grunt","year":"2022","journal-title":"Progress in Biophysics and Molecular Biology"},{"issue":"13","key":"10.1016\/j.bioorg.2024.107228_b0015","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.3390\/cancers14133158","article-title":"Economic perspective of cancer care and its consequences for vulnerable groups","volume":"14","author":"Haier","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107228_b0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3322\/caac.21443","article-title":"The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment","volume":"68","author":"Carrera","year":"2018","journal-title":"CA; a Cancer Journal for Clinicians"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107228_b0025","doi-asserted-by":"crossref","first-page":"e000285","DOI":"10.1136\/esmoopen-2017-000285","article-title":"Global cancer control: responding to the growing burden, rising costs and inequalities in access","volume":"3","author":"Prager","year":"2018","journal-title":"ESMO Open"},{"issue":"16","key":"10.1016\/j.bioorg.2024.107228_b0030","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.3390\/cancers13164006","article-title":"Stem cell theory of cancer: origin of tumor heterogeneity and plasticity","volume":"13","author":"Tu","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2024.107228_b0035","doi-asserted-by":"crossref","unstructured":"S.A.F. Rostom, M.A. Shalaby, M.A. El-Demellawy, Polysubstituted pyrazoles, part 5.11For part 4: see Ref. [18]. Synthesis of new 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazole-3-carboxylic acid hydrazide analogs and some derived ring systems. A novel class of potential antitumor and anti-HCV agents, European Journal of Medicinal Chemistry 38(11) (2003) 959-974.","DOI":"10.1016\/j.ejmech.2003.08.003"},{"issue":"Suppl 1","key":"10.1016\/j.bioorg.2024.107228_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.2011-S1-01","article-title":"Triple-negative breast cancer: an unmet medical need","volume":"16","author":"Hudis","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.bioorg.2024.107228_b0045","doi-asserted-by":"crossref","unstructured":"H.E. Ahmed, M.A. El-Nassag, A.H. Hassan, R.M. Okasha, S. Ihmaid, A.M. Fouda, T.H. Afifi, A. Aljuhani, A.M.J.J.o.e.i. El-Agrody, m. chemistry, Introducing novel potent anticancer agents of 1H-benzo [f] chromene scaffolds, targeting c-Src kinase enzyme with MDA-MB-231 cell line anti-invasion effect, 33(1) (2018) 1074-1088.","DOI":"10.1080\/14756366.2018.1476503"},{"key":"10.1016\/j.bioorg.2024.107228_b0050","doi-asserted-by":"crossref","unstructured":"A. Al Sheikh Ali, D. Khan, A. Naqvi, F.F. Al-blewi, N. Rezki, M.R. Aouad, M. Hagar, Design, Synthesis, Molecular Modeling, Anticancer Studies, and Density Functional Theory Calculations of 4-(1,2,4-Triazol-3-ylsulfanylmethyl)-1,2,3-triazole Derivatives, ACS Omega 6(1) (2021) 301-316.","DOI":"10.1021\/acsomega.0c04595"},{"key":"10.1016\/j.bioorg.2024.107228_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131568","article-title":"Discovery of triaromatic flexible agents bearing 1,2,3-Triazole with selective and potent anti-breast cancer activity and CDK9 inhibition supported by molecular dynamics","volume":"1249","author":"Ihmaid","year":"2022","journal-title":"Journal of Molecular Structure"},{"key":"10.1016\/j.bioorg.2024.107228_b0060","doi-asserted-by":"crossref","unstructured":"M. Alsehli, A. Aljuhani, S.K. Ihmaid, S.M. El-Messery, D.I.A. Othman, A.-A.A.A. El-Sayed, H.E.A. Ahmed, N. Rezki, M.R. Aouad, Design and Synthesis of Benzene Homologues Tethered with 1,2,4-Triazole and 1,3,4-Thiadiazole Motifs Revealing Dual MCF-7\/HepG2 Cytotoxic Activity with Prominent Selectivity via Histone Demethylase LSD1 Inhibitory Effect, 23(15) (2022) 8796.","DOI":"10.3390\/ijms23158796"},{"key":"10.1016\/j.bioorg.2024.107228_b0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phrs.2015.01.003","article-title":"Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors","volume":"94","author":"Roskoski","year":"2015","journal-title":"Pharmacological Research"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107228_b0070","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.cellbio.13.1.513","article-title":"Cellular functions regulated by Src family kinases","volume":"13","author":"Thomas","year":"1997","journal-title":"Annual Review of Cell and Developmental Biology"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107228_b0075","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bbrc.2004.09.171","article-title":"Src protein\u2013tyrosine kinase structure and regulation","volume":"324","author":"Roskoski","year":"2004","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"6617","key":"10.1016\/j.bioorg.2024.107228_b0080","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/385595a0","article-title":"Three-dimensional structure of the tyrosine kinase c-Src","volume":"385","author":"Xu","year":"1997","journal-title":"Nature"},{"issue":"49","key":"10.1016\/j.bioorg.2024.107228_b0085","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1038\/sj.onc.1203912","article-title":"Role of Src expression and activation in human cancer","volume":"19","author":"Irby","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2024.107228_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106934","article-title":"Recent advances of small-molecule c-Src inhibitors for potential therapeutic utilities","volume":"142","author":"Dang","year":"2024","journal-title":"Bioorganic Chemistry"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107228_b0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/14728222.11.1.91","article-title":"The Src signaling pathway: a potential target in melanoma and other malignancies","volume":"11","author":"Homsi","year":"2007","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107228_b0100","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/annonc\/mdq757","article-title":"Src: a potential target for the treatment of triple-negative breast cancer","volume":"22","author":"Tryfonopoulos","year":"2011","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.bioorg.2024.107228_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106552","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update","volume":"187","author":"Roskoski","year":"2023","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.bioorg.2024.107228_b0110","doi-asserted-by":"crossref","unstructured":"W.A. Zaki, S.M. El-Sayed, M. Alswah, A. El-Morsy, A.H. Bayoumi, A.S. Mayhoub, W.H. Moustafa, A.A. Awaji, E.J. Roh, A.H.E. Hassan, K. Mahmoud, Design, Synthesis, In Vitro, and In Silico Studies of New N(5)-Substituted-pyrazolo[3,4-d]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors, Pharmaceuticals (Basel) 16(11) (2023).","DOI":"10.3390\/ph16111593"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107228_b0115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.21608\/ajps.2021.187757","article-title":"Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine derivatives of expected anticancer activity","volume":"64","author":"Alswah","year":"2021","journal-title":"Al-Azhar Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.bioorg.2024.107228_b0120","doi-asserted-by":"crossref","unstructured":"M.A. Santucci, V. Corradi, M. Mancini, F. Manetti, M. Radi, S. Schenone, M. Botta, C6\u2010Unsubstituted Pyrazolo [3, 4\u2010d] pyrimidines Are Dual Src\/Abl Inhibitors Effective against Imatinib Mesylate Resistant Chronic Myeloid Leukemia Cell Lines, ChemMedChem; Chemistry Enabling Drug Discovery 4(1) (2009) 118-126.","DOI":"10.1002\/cmdc.200800320"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107228_b0125","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1021\/acs.jmedchem.6b00065","article-title":"Rapid discovery and structure\u2013activity relationships of pyrazolopyrimidines that potently suppress breast cancer cell growth via SRC kinase inhibition with exceptional selectivity over ABL kinase","volume":"59","author":"Fraser","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"issue":"19","key":"10.1016\/j.bioorg.2024.107228_b0130","doi-asserted-by":"crossref","first-page":"15026","DOI":"10.3390\/ijms241915026","article-title":"Development of Novel Class of Phenylpyrazolo [3, 4-d] pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies","volume":"24","author":"Aljohani","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107228_b0135","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1021\/acs.jmedchem.6b00065","article-title":"Rapid discovery and structure-activity relationships of pyrazolopyrimidines that potently suppress breast cancer cell growth via src kinase inhibition with exceptional selectivity over abl kinase","volume":"59","author":"Fraser","year":"2016","journal-title":"Journal of Medicinal Chemistry"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107228_b0140","doi-asserted-by":"crossref","first-page":"10685","DOI":"10.3390\/molecules161210685","article-title":"Novel pyrazolo [3, 4-d] pyrimidine derivatives as potential antitumor agents: exploratory synthesis, preliminary structure-activity relationships, and in vitro biological evaluation","volume":"16","author":"He","year":"2011","journal-title":"Molecules"},{"issue":"19","key":"10.1016\/j.bioorg.2024.107228_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241915026","article-title":"Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies","volume":"24","author":"Aljohani","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107228_b0150","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1080\/14756366.2022.2112575","article-title":"Discovery of new 1H-pyrazolo[3,4-d]pyrimidine derivatives as anticancer agents targeting EGFR(WT) and EGFR(T790M)","volume":"37","author":"Gaber","year":"2022","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2024.107228_b0155","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bioorg.2018.06.017","article-title":"Design, synthesis and anticancer evaluation of 1H-pyrazolo [3, 4-d] pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers","volume":"80","author":"Gaber","year":"2018","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/j.bioorg.2024.107228_b0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejmech.2018.02.031","article-title":"Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus","volume":"148","author":"Elsebaei","year":"2018","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107228_b0165","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/acsinfecdis.9b00211","article-title":"Balancing physicochemical properties of phenylthiazole compounds with antibacterial potency by modifying the lipophilic side chain","volume":"6","author":"Mancy","year":"2019","journal-title":"ACS Infectious Diseases"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107228_b0170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jhet.5570390135","article-title":"Synthesis and spectroscopic properties of 15n-labelled 1, 2, 4-thiadiazoles","volume":"39","author":"Pavlik","year":"2002","journal-title":"Journal of Heterocyclic Chemistry"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107228_b0175","first-page":"165","article-title":"Design, synthesis and antimicrobial evaluation of some novel quinoline derivatives","volume":"2","author":"El-Gamal","year":"2015","journal-title":"Pharm Pharmacol Int J"},{"key":"10.1016\/j.bioorg.2024.107228_b0180","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s00044-012-0084-0","article-title":"Synthesis of novel 2-alkyl-4-substituted-amino-pyrazolo [3, 4-d] pyrimidines as new leads for anti-bacterial and anti-cancer activity","volume":"22","author":"Devarakonda","year":"2013","journal-title":"Medicinal Chemistry Research"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107228_b0185","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1016\/j.bmc.2017.03.002","article-title":"Design and synthesis of pyrazolo [3, 4-d] pyrimidines: nitric oxide releasing compounds targeting hepatocellular carcinoma","volume":"25","author":"Elshaier","year":"2017","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2024.107228_b0190","doi-asserted-by":"crossref","unstructured":"A. Marwaha, J. White, F. El_Mazouni, S.A. Creason, S. Kokkonda, F.S. Buckner, S.A. Charman, M.A. Phillips, P.K. Rathod, Bioisosteric transformations and permutations in the triazolopyrimidine scaffold to identify the minimum pharmacophore required for inhibitory activity against Plasmodium falciparum dihydroorotate dehydrogenase, Journal of medicinal chemistry 55(17) (2012) 7425-7436.","DOI":"10.1021\/jm300351w"},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2024.107228_b0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/j.bioorg.2024.107228_b0200","doi-asserted-by":"crossref","unstructured":"F. Demirci, K.H.C. Ba\u015fer, Bioassay Techniques for Drug Development By Atta-ur-Rahman, M. Iqbal Choudhary (HEJRIC, University of Karachi, Pakistan), William J. Thomsen (Areana Pharmaceuticals, San Diego, CA). Harwood Academic Publishers, Amsterdam, The Netherlands. 2001. xii + 223 pp. 15.5 \u00d7 23.5 cm. $79.00. ISBN 90-5823-051-1, Journal of Natural Products 65(7) (2002) 1086-1087.","DOI":"10.1021\/np020725b"},{"key":"10.1016\/j.bioorg.2024.107228_b0205","series-title":"William J","author":"Atta-ur-Rahman","year":"2001"},{"key":"10.1016\/j.bioorg.2024.107228_b0210","first-page":"1","article-title":"The anticancer and anti-inflammatory activity screening of pyridazinone-based analogs against human epidermoid skin cancer with detailed mechanistic analyses","author":"Bershawy","year":"2023","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"key":"10.1016\/j.bioorg.2024.107228_b0215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13321-016-0130-x","article-title":"Improving chemical similarity ensemble approach in target prediction","volume":"8","author":"Wang","year":"2016","journal-title":"Journal of Cheminformatics"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107228_b0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Research"},{"issue":"D1","key":"10.1016\/j.bioorg.2024.107228_b0225","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Research"},{"issue":"23","key":"10.1016\/j.bioorg.2024.107228_b0230","first-page":"3073","article-title":"Shaping the interaction landscape of bioactive molecules","volume":"29","author":"Gfeller","year":"2013","journal-title":"Bioinformatics (oxford, England)"},{"key":"10.1016\/j.bioorg.2024.107228_b0235","article-title":"Cancer invasion and metastasis: molecular and cellular perspective, Madame Curie Bioscience Database [Internet], Landes","author":"Martin","year":"2013","journal-title":"Bioscience"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107228_b0240","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/jof7030188","article-title":"Induction of apoptosis in MDA-MB-231 cells treated with the methanol extract of lichen Physconia hokkaidensis","volume":"7","author":"Noh","year":"2021","journal-title":"Journal of Fungi"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107228_b0245","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1006\/jmbi.1998.2369","article-title":"Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine","volume":"285","author":"Lamers","year":"1999","journal-title":"Journal of Molecular Biology"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107228_b0250","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10616-012-9481-y","article-title":"Beyond annexin V: fluorescence response of cellular membranes to apoptosis","volume":"65","author":"Demchenko","year":"2013","journal-title":"Cytotechnology"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107228_b0255","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/138161210789941793","article-title":"Mechanisms of tumor cell necrosis","volume":"16","author":"Proskuryakov","year":"2010","journal-title":"Current Pharmaceutical Design"},{"issue":"8","key":"10.1016\/j.bioorg.2024.107228_b0260","first-page":"2492","article-title":"Noninvasive imaging of apoptosis and its application in cancer therapeutics, Clinical cancer research: an official journal of the American Association for","volume":"14","author":"Coppola","year":"2008","journal-title":"Cancer Research"},{"issue":"9","key":"10.1016\/j.bioorg.2024.107228_b0265","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/cdd.2012.21","article-title":"Src tyrosine kinase inhibits apoptosis through the Erk1\/2- dependent degradation of the death accelerator Bik","volume":"19","author":"Lopez","year":"2012","journal-title":"Cell Death & Differentiation"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107228_b0270","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1021\/acsmedchemlett.9b00679","article-title":"Predictive gene signature for pyrazolopyrimidine derivative c-src inhibitor 10a sensitivity in melanoma cells","volume":"11","author":"Kucukkaraduman","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bioorg.2024.107228_b0275","doi-asserted-by":"crossref","unstructured":"H.E. Ahmed, M.A. El-Nassag, A.H. Hassan, H.M. Mohamed, A.H. Halawa, R.M. Okasha, S. Ihmaid, S.M.A. El-Gilil, E.S. Khattab, A.M.J.J.o.M.S. Fouda, Developing lipophilic aromatic halogenated fused systems with specific ring orientations, leading to potent anticancer analogs and targeting the c-Src Kinase enzyme, 1186 (2019) 212-223.","DOI":"10.1016\/j.molstruc.2019.03.012"},{"key":"10.1016\/j.bioorg.2024.107228_b0280","doi-asserted-by":"crossref","unstructured":"T.I. de Santana, M.d.O. Barbosa, P.A.T.d.M. Gomes, A.C.N. da Cruz, T.G. da Silva, A.C.L. Leite, Synthesis, anticancer activity and mechanism of action of new thiazole derivatives, European journal of medicinal chemistry 144 (2018) 874-886.","DOI":"10.1016\/j.ejmech.2017.12.040"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107228_b0285","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/cas.13572","article-title":"c-Src inhibitor selectively inhibits triple-negative breast cancer overexpressed Vimentin in vitro and in vivo","volume":"109","author":"Lou","year":"2018","journal-title":"Cancer Science"},{"key":"10.1016\/j.bioorg.2024.107228_b0290","article-title":"Timosaponin AIII Induces G2\/M Arrest and Apoptosis in Breast Cancer by Activating the ATM\/Chk2 and p38 MAPK Signaling Pathways","volume":"11","author":"Zhang","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107228_b0295","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13277-010-0106-9","article-title":"Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity","volume":"32","author":"Maity","year":"2011","journal-title":"Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107228_b0300","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.fjps.2016.02.002","article-title":"Pyrazolo[3,4-d]pyrimidine based scaffold derivatives targeting kinases as anticancer agents","volume":"2","author":"Ismail","year":"2016","journal-title":"Future Journal of Pharmaceutical Sciences"},{"issue":"16","key":"10.1016\/j.bioorg.2024.107228_b0305","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612724","article-title":"Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents","volume":"24","author":"Zhang","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107228_b0310","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ardp.201300402","article-title":"Role of AMP-activated protein kinase in cancer therapy","volume":"347","author":"Rehman","year":"2014","journal-title":"Archiv Der Pharmazie"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107228_b0315","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12935-021-02396-8","article-title":"p53 signaling in cancer progression and therapy","volume":"21","author":"Marei","year":"2021","journal-title":"Cancer Cell International"},{"key":"10.1016\/j.bioorg.2024.107228_b0320","doi-asserted-by":"crossref","unstructured":"R.E. Maarouf, K.S. Azab, N.M. El Fatih, H. Helal, L. Rashed, Withania somnifera Alter BCL2\/Bax signaling and trigger apoptosis of MCF-7 and MDA-MB231 breast cancer cells exposed to \u03b3-radiation, Human & Experimental Toxicology 42 (2023) 09603271231180849.","DOI":"10.1177\/09603271231180849"},{"key":"10.1016\/j.bioorg.2024.107228_b0325","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.2147\/DDDT.S130349","article-title":"Anti-proliferative, apoptotic induction, and anti-migration effects of hemi-synthetic 1'S-1'-acetoxychavicol acetate analogs on MDA-MB-231 breast cancer cells","volume":"11","author":"Liew","year":"2017","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107228_b0330","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.bmcl.2011.01.047","article-title":"Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities","volume":"21","author":"Kumar","year":"2011","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107228_b0335","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nrc1366","article-title":"A renaissance for SRC","volume":"4","author":"Yeatman","year":"2004","journal-title":"Nature Reviews. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107228_b0340","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcp.22011","article-title":"Src signaling in cancer invasion","volume":"223","author":"Guarino","year":"2010","journal-title":"Journal of Cellular Physiology"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107228_b0345","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1023\/A:1023772912750","article-title":"Src family kinases in tumor progression and metastasis","volume":"22","author":"Summy","year":"2003","journal-title":"Cancer Metastasis Reviews"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107228_b0350","first-page":"114","article-title":"Src in cancer: deregulation and consequences for cell behaviour","volume":"1602","author":"Frame","year":"2002","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"17","key":"10.1016\/j.bioorg.2024.107228_b0355","first-page":"4773","article-title":"Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product","volume":"52","author":"Ottenhoff-Kalff","year":"1992","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107228_b0360","first-page":"383","article-title":"c-Src protein expression is increased in human breast cancer","volume":"180","author":"Verbeek","year":"1996","journal-title":"An Immunohistochemical and Biochemical Analysis, the Journal of Pathology"},{"issue":"11","key":"10.1016\/j.bioorg.2024.107228_b0365","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1021\/jm060236z","article-title":"A combination of docking\/dynamics simulations and pharmacophoric modeling to discover new dual c-Src\/Abl kinase inhibitors","volume":"49","author":"Manetti","year":"2006","journal-title":"Journal of Medicinal Chemistry"},{"issue":"9","key":"10.1016\/j.bioorg.2024.107228_b0370","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2174\/1381612043452721","article-title":"Recent development and application of virtual screening in drug discovery: an overview","volume":"10","author":"Tingjun","year":"2004","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.bioorg.2024.107228_b0375","first-page":"781","article-title":"Discovery of novel phthalimide analogs: Synthesis, antimicrobial and antitubercular screening with molecular docking studies","volume":"15","author":"Rateb","year":"2016","journal-title":"EXCLI Journal"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107228_b0380","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise?","volume":"2","author":"van de Waterbeemd","year":"2003","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"1\u20133","key":"10.1016\/j.bioorg.2024.107228_b0385","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings1","volume":"46","author":"Lipinski","year":"2001","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107228_b0390","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/138955711795843383","article-title":"Synthesis and cytotoxic activity of new beta-carboline derivatives","volume":"11","author":"Peduto","year":"2011","journal-title":"Mini Reviews in Medicinal Chemistry"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107228_b0395","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1023\/A:1020444330011","article-title":"Rate-limited steps of human oral absorption and QSAR Studies","volume":"19","author":"Zhao","year":"2002","journal-title":"Pharmaceutical Research"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107228_b0400","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0166-1280(94)03783-H","article-title":"The relationship of charge transfer complexes to frontier orbital energies in QSAR","volume":"331","author":"Clare","year":"1995","journal-title":"Journal of Molecular Structure; Theochem"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107228_b0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1139(00)00324-9","article-title":"Predicting the reactivity of fluorinated compounds with copper using semi-empirical calculations","volume":"107","author":"Heaton","year":"2001","journal-title":"Journal of Fluorine Chemistry"},{"key":"10.1016\/j.bioorg.2024.107228_b0410","doi-asserted-by":"crossref","unstructured":"H.E.A. Ahmed, A. Amer, S.A. Senior, S. Ihmaid, M. Almalghrabi, A.-M.E. Massry, S. Ahmed, A. Musa, M.A. Almikhlafi, S.A. Salama, A.A. Elhenawy, Extensive Study of DFT-Quantum Calculations Based QSAR Modeling of Fused 1,2,4-Triazine Derivatives Revealed Potent CYP1A1 Inhibitors, 21(07) (2022) 741-758.","DOI":"10.1142\/S2737416522300036"},{"key":"10.1016\/j.bioorg.2024.107228_b0415","first-page":"1","article-title":"The anticancer and EGFR-TK\/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro, and in silico mechanistic investigations","author":"Musa","year":"2023","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"10.1016\/j.bioorg.2024.107228_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104835","article-title":"Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7\/HepG2 cytotoxicity: Synthesis EGFR inhibitory effect, and metabolic stability","volume":"111","author":"Ihmaid","year":"2021","journal-title":"Bioorganic Chemistry"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107228_b0425","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/jmbi.1994.1129","article-title":"Formation of two-dimensional arrays of annexin V on phosphatidylserine-containing liposomes","volume":"236","author":"Pigault","year":"1994","journal-title":"Journal of Molecular Biology"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107228_b0430","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/bj3280447","article-title":"Relocation of annexin V to platelet membranes is a phosphorylation-dependent process","volume":"328","author":"Trotter","year":"1997","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.bioorg.2024.107228_b0435","series-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"1989"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107228_b0440","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0003-2697(81)90281-5","article-title":"\u201cWestern blotting\u201d; electrophoretic transfer of proteins from sodium dodecyl sulfate\u2013polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A","volume":"112","author":"Burnette","year":"1981","journal-title":"Analytical Biochemistry"},{"issue":"14","key":"10.1016\/j.bioorg.2024.107228_b0445","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"Journal of Computational Chemistry"},{"key":"10.1016\/j.bioorg.2024.107228_b0450","unstructured":"Molecular Operating Environment (MOE) Chemical Computing Group, Quebec, Canada. 2012; http:\/\/www.chemcomp.com. Accessed on 30\/02\/2013 (2012)."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824001330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824001330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:24:51Z","timestamp":1783603491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824001330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":90,"alternative-id":["S0045206824001330"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107228","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N- and s-substituted Pyrazolopyrimidines: A promising new class of potent c-Src kinase inhibitors with prominent antitumor activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107228"}}